Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

Oxford–AstraZeneca COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by the Oxford University and British-Swedish company AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

0 shares	Share Tweet Save Post Send


UK revises travel policy, implies issue is India's vaccine certificate \| Covishield \| Oneindia News The UK has revised its travel policy to include Covishield as an approved vaccine after a furious India warned of ‘reciprocal measures’, but Indians double-vaccinated with the shot still have to.. Credit: Oneindia Duration: 01:40Published 6 days ago

India to retaliate against new jab policy of United Kingdom for travelers \| Oneindia News The new jab policy by the United Kingdom has raised issue in India. India threatened to retaliate against new British travel rules putting those who are vaccinated with Covishield in the category of.. Credit: Oneindia Duration: 01:52Published 1 week ago

PM promotes Covid jab to sceptical Brazilian president Boris Johnson has hailed the UK's AstraZeneca Covid jab as a "great vaccine" during a meeting with Brazilian president Jair Bolsonaro, who has previously shared vaccine-sceptic views. The prime.. Credit: ODN Duration: 01:21Published 1 week ago

Joe Biden urges Afghan leaders to fight against Taliban \| Withdrawing US troops \| Oneindia News US President Joe Biden urged Afghanistan’s leaders to fight for their homeland; Today, Lok Sabha was adjourned indefinitely today, bringing an end to the tumultuous Monsoon session of Parliament;.. Credit: Oneindia Duration: 02:26Published on August 11, 2021

ICMR study suggests mixing Covaxin and Covishield can work better against Covid-19 \| Oneindia News According to a study by the Indian Council of Medical Research, mixing and matching of the Covid-19 vaccines available in India that are Covaxin and Covishield have shown better results in building.. Credit: Oneindia Duration: 01:17Published on August 8, 2021


Creator of Oxford vaccine made into Barbie doll Professor Dame Sarah Gilbert has been honoured as a ‘Barbie Role Model’ for her work creating the Oxford vaccine.It is hoped the Barbie doll will inspire girls to consider a career in science. Credit: PA - Press Association STUDIO Duration: 01:07Published on August 3, 2021

Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too\| Oneindia News Top political leaders today expressed anguish over the allegedrape and murderof a nine-year-old Dalit girl in the Delhi Cantonment area on Sunday. The government has said today that the pandemic is.. Credit: Oneindia Duration: 03:00Published on August 3, 2021

You Might Like

No change in Covishield dose gap: NTAGI chief Dr N K Arora, chairman of the Covid-19 working group of National Technical Advisory Group on Immunisation (NTAGI), on Saturday ruled out any changes in the gap between two doses of Covishield citing.. IndiaTimes - Published 3 days ago
Italy recognises Covishield; travellers jabbed in India eligible for Green Pass: Indian embassy in Rome Italy has become the latest EU member to recognise WHO-approved Covishield, after several others like Germany, Switzerland, France and Spain. Indian vaccine card holders are now eligible for GreenPass,.. IndiaTimes - Published 4 days ago
No technical concern in Covishield certificate process, says UK in sign of conciliation IndiaTimes - Published 5 days ago

Covishield: Neither side raised concerns with each other’s certification process, says UK envoy IndiaTimes - Published 5 days ago
Centre files plea against allowing second dose of Covishield earlier, says it will derail policy IndiaTimes - Published 6 days ago
Covishield approved in UK, travel advisory revised after strong objections from India The UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory. DNA - Published 6 days ago

India warns UK of reciprocal steps over vaccine ‘discrimination’ “Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing to the inconsistency in the rules.. IndiaTimes - Published 1 week ago
India says UK govt's stand on Covishield 'discriminatory', warns of 'reciprocal action' IndiaTimes - Published 1 week ago
Faceoff: UK's non-recognition of Covishield creates storm on Twitter The UK government’s new international travel rules putting those who are vaccinated with Covishield in the category of the 'unvaccinated' have been blasted as "offensive", "bizarre" and "racist". IndiaTimes - Published 1 week ago
India to protest against new UK vaccine travel rules not recognising Covishield External Affairs Minister S Jaishankar is likely to speak to the newly-appointed British Foreign Secretary Liz Truss on UK not recognising Covishield. DNA - Published 1 week ago

Centre places purchase order with Serum Institute for 66 crore Covishield doses to be supplied by Dec: Sources IndiaTimes - Published 3 weeks ago
Allow second Covishield dose after 4 weeks from first for those who want it early: Kerala HC to Centre IndiaTimes - Published 3 weeks ago
Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these steps India is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake DNA - Published 3 weeks ago	84 days gap between Covishield vaccine doses provides best protection against COVID-19: Centre The duration of 84 days between first and second doses of the Covishield COVID-19 vaccine gives the best protection against coronavirus, Centre said DNA - Published on September 4, 2021
Fake Covishield doses in Southeast Asia, Africa: UP govt issues alert to all DMs, CMOs The Uttar Pradesh government has issued an alert after fake Covishield doses were found in Southeast Asia and Africa. DNA - Published on September 1, 2021	No plan yet to revise Covishield dose gap, clarifies govt IndiaTimes - Published on August 26, 2021
Government mulls reducing time gap between Covishield doses, say sources IndiaTimes - Published on August 26, 2021	Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report IndiaTimes - Published on August 26, 2021
COVID-19: Gap between two doses of Covishield may be reduced At present, over 59 crore vaccine doses have been administered in the country and efforts are being made by the government to expedite the process. DNA - Published on August 24, 2021	84-day gap in Covishield doses due to efficacy or availability? Kerala HC asks Centre Justice PB Suresh Kumar said that if efficacy was the reason, he was "worried" as he got the second dose within four-six weeks of the first dose. DNA - Published on August 24, 2021
Kerala man files plea in court for Covishield after taking both doses of Covaxin, read why The man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin. DNA - Published on August 18, 2021	DCGI gives nod to conduct study on mixing Covaxin, Covishield The Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines. The research study will be done by Christian Medical College, Vellore, said.. IndiaTimes - Published on August 11, 2021
Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K Paul DCGI has approved a proposal from the CMC Vellore to carry out trials on the mixed use of COVID-19 vaccines, Covishield and Covaxin in people. DNA - Published on August 11, 2021	Covishield-Covaxin mix offers better shield, says ICMR study The study examined 18 individuals in UP who inadvertently received Covishield as the first jab and Covaxin as the second. "The findings suggest that immunisation with a combination of an adenovirus.. IndiaTimes - Published on August 8, 2021
136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-December More than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the.. IndiaTimes - Published on August 6, 2021	Government likely to reduce Covishield dose gap but are you eligible? Find answer The decision to increase the gap of dosage to 12-16 weeks was met with criticism as the move was interpreted as an attempt to manage vaccine scarcity. DNA - Published on August 5, 2021
CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two Covid-19.. IndiaTimes - Published on July 29, 2021	Covishield generates 93% protection, says AFMC study Covishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta variant, officials said citing a vaccine.. IndiaTimes - Published on July 27, 2021
Covishield reduces fresh infections by 93%, deaths by 98%: AFMS study A study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the Defence Ministry said on Tuesday. IndiaTimes - Published on July 27, 2021	NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: Govt The recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the government informed Rajya Sabha on.. IndiaTimes - Published on July 27, 2021
France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countries The European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel DNA - Published on July 18, 2021	17 European nations have given nod to Covishield: Serum Institute of India IndiaTimes - Published on July 17, 2021
15 of 27 member countries of the EU have approved Covishield: Poonawalla IndiaTimes - Published on July 17, 2021	No application received from SII for EU authorisation of Covishield vaccine: EMA Poonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter. DNA - Published on July 17, 2021Also reported by •IndiaTimes
Government buying Covishield at Rs 215, Covaxin at Rs 225 The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source. “We are on path to achieving the.. IndiaTimes - Published on July 16, 2021	Government orders 66 crore vaccine doses worth Rs 14,505 crore The government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine.. IndiaTimes - Published on July 15, 2021
Switzerland, Iceland, 7 EU nations approve Covishield for travel entry Switzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under.. IndiaTimes - Published on July 1, 2021	India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy Controversy unfolded over EU's move to not include India's Covishield and Covaxin under its 'Green Passport' scheme for its Digital COVID Certificate. DNA - Published on July 1, 2021
Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’ Serum Institute of India CEO Adar Poonawalla played down on Wednesday Covishield not getting approved for the EU green pass, saying, "It is not a controversy at all. It’s been blown out of.. IndiaTimes - Published on June 30, 2021	Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU India will not recognise EU’s digital covid certificate until the EU includes Indian vaccines Covishield and Covaxin in the certificate. In what is certainly the first diplomatic retaliatory.. IndiaTimes - Published on June 30, 2021
'Matter of time': SII's Poonawalla confident of getting EU green pass for Covishield Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter of time" and is expected in about a.. IndiaTimes - Published on June 30, 2021	Indians in a fix, Jaishankar raises green pass for Covishield with EU IndiaTimes - Published on June 30, 2021
Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines EMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria. DNA - Published on June 29, 2021	India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the.. IndiaTimes - Published on June 29, 2021
Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said.. IndiaTimes - Published on June 29, 2021	France 'actively working' on Indian concerns over Covishield's absence on EU Green Pass For market authorization of Covishield for use in the EU, the SII needs to apply for EMA, which then conducts a verification of the production site. DNA - Published on June 29, 2021
EU agency clarifies on Covishield nod IndiaTimes - Published on June 29, 2021	Covishield not a ‘green pass’, Europe-bound Indians fret BENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of.. IndiaTimes - Published on June 29, 2021
SII seeks govt help for adding Covishield in EU vax passport list IndiaTimes - Published on June 28, 2021	Approval to Covishield would be considered should we receive marketing authorisation application: EU agency The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said.. IndiaTimes - Published on June 28, 2021

Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

Oxford–AstraZeneca COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

No change in Covishield dose gap: NTAGI chief

Italy recognises Covishield; travellers jabbed in India eligible for Green Pass: Indian embassy in Rome

No technical concern in Covishield certificate process, says UK in sign of conciliation

Covishield: Neither side raised concerns with each other’s certification process, says UK envoy

Centre files plea against allowing second dose of Covishield earlier, says it will derail policy

Covishield approved in UK, travel advisory revised after strong objections from India

India warns UK of reciprocal steps over vaccine ‘discrimination’

India says UK govt's stand on Covishield 'discriminatory', warns of 'reciprocal action'

Faceoff: UK's non-recognition of Covishield creates storm on Twitter

India to protest against new UK vaccine travel rules not recognising Covishield

Centre places purchase order with Serum Institute for 66 crore Covishield doses to be supplied by Dec: Sources

Allow second Covishield dose after 4 weeks from first for those who want it early: Kerala HC to Centre

Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these steps

84 days gap between Covishield vaccine doses provides best protection against COVID-19: Centre

Fake Covishield doses in Southeast Asia, Africa: UP govt issues alert to all DMs, CMOs

No plan yet to revise Covishield dose gap, clarifies govt

Government mulls reducing time gap between Covishield doses, say sources

Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report

COVID-19: Gap between two doses of Covishield may be reduced

84-day gap in Covishield doses due to efficacy or availability? Kerala HC asks Centre

Kerala man files plea in court for Covishield after taking both doses of Covaxin, read why

DCGI gives nod to conduct study on mixing Covaxin, Covishield

Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K Paul

Covishield-Covaxin mix offers better shield, says ICMR study

136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-December

Government likely to reduce Covishield dose gap but are you eligible? Find answer

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

Covishield generates 93% protection, says AFMC study

Covishield reduces fresh infections by 93%, deaths by 98%: AFMS study

NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: Govt

France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countries

17 European nations have given nod to Covishield: Serum Institute of India

15 of 27 member countries of the EU have approved Covishield: Poonawalla

No application received from SII for EU authorisation of Covishield vaccine: EMA

Government buying Covishield at Rs 215, Covaxin at Rs 225

Government orders 66 crore vaccine doses worth Rs 14,505 crore

Switzerland, Iceland, 7 EU nations approve Covishield for travel entry

India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy

Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’

Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU

'Matter of time': SII's Poonawalla confident of getting EU green pass for Covishield

Indians in a fix, Jaishankar raises green pass for Covishield with EU

Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

France 'actively working' on Indian concerns over Covishield's absence on EU Green Pass

EU agency clarifies on Covishield nod

Covishield not a ‘green pass’, Europe-bound Indians fret

SII seeks govt help for adding Covishield in EU vax passport list

Approval to Covishield would be considered should we receive marketing authorisation application: EU agency